Live feed
Filing
SC 13D
SC 13D0001213900-24-096045·Eilean Therapeutics, LLC
Schedule 13D ownership disclosure
Lomond Therapeutics Holdings, Inc.
Security class unavailable · CUSIP: 54173L101
Event date: 2024-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 53.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-096045
- Form type
- SC 13D
- Filer
- Eilean Therapeutics, LLC
- CIK
- CIK 2042386
- Filed
- Nov 08, 2024
- Reporting period
- Nov 01, 2024
- Description
- Schedule 13D beneficial ownership